Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Voyager Therapeutics, Inc. (VYGR) had Weighted-Average Shares Outstanding (Diluted) of 58.67M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$5.20M |
|
$-33.38M |
|
-- |
|
$5.20M |
|
$41.83M |
|
$-36.62M |
|
$3.26M |
|
$-33.37M |
|
$-33.37M |
|
$-33.38M |
|
$-33.38M |
|
$-33.38M |
|
$-33.38M |
|
$-36.62M |
|
$-36.35M |
|
58.67M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
58.67M |
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$227.89M |
|
$13.92M |
|
$94.21M |
|
$322.10M |
|
$41.98M |
|
-- |
|
$36.17M |
|
$78.16M |
|
$243.94M |
|
$243.94M |
|
$243.94M |
|
55.44M |
|
| Cash Flow Statement Financials | |
$-71.16M |
|
$43.13M |
|
$0.59M |
|
$74.24M |
|
$46.81M |
|
$-27.43M |
|
$7.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-704.33% |
|
-704.33% |
|
-- |
|
-641.67% |
|
-641.96% |
|
$-72.92M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
2.06 |
|
43.70 |
|
-13.68% |
|
-13.68% |
|
-10.36% |
|
-13.68% |
|
$4.40 |
|
$-1.24 |
|
$-1.21 |
|